Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Magnetic Resonance Imaging × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 27 Breast Neoplasms 26 Brain Neoplasms 19 Neoplasms 14 Glioma 8 Uterine Cervical Neoplasms 6 Pancreatic Neoplasms 6 Lymphoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 5 Lymphoma, Non-Hodgkin 5 Glioblastoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Lung Neoplasms 4 Liver Neoplasms 4 Disease 4 Colonic Neoplasms 4 Central Nervous System Neoplasms 4 Astrocytoma 4 Spinal Cord Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Esophageal Neoplasms 3 Carcinoma in Situ 3 Retinoblastoma 2 Pathologic Complete Response 2 Oligodendroglioma 2

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5 pimonidazole 4 fluoroazomycin arabinoside 4 TH 302 4 Radiotherapy 3 Propofol 3 Injections 3 pomalidomide 1 gadobutrol 1 fluoromisonidazole 1 fludarabine 1 alovudine 1 Tirapazamine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Temozolomide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Pancreaticoduodenectomy 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Letrozole 1 Ketamine 1 Ipilimumab 1 Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05029258 2025-01-20

Bio-CHECC

University of Manchester

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡